Abstracts Archive - Page 247 of 1683 - ATC Abstracts

2021 American Transplant Congress
Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Elevated Plasma Oxalate Level Not Due to Primary Hyperoxaluria
D. Khan, N. Zhang, M. Keddis
Mayo Clinic, Phoenix, AZ
*Purpose: Patients with elevated systemic oxalate burden due to enteric etiologies are at increased risk for calcium oxalate deposition causing ESRD. The objective of this…
2021 American Transplant Congress
Psmp is Discriminative for Chronic Active Antibody-Mediated Rejection and Predicts Graft Risk After Kidney Transplantation
Y. Fu, P. Zhan
Tianjin First Central Hospital, Tianjin, China
*Purpose: Chronic active antibody-mediated rejection (c-aABMR) is an intermediate process in the development of chronic antibody-mediated rejection (c-ABMR), a key problem in the long-term failure…
2021 American Transplant Congress
Recurrence and Outcome of Anti-GBM Glomerulonephritis After Kidney Transplantation: A Belgian Multicenter Study
S. Coche
Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
*Purpose: Recurrence of anti-glomerular basement membrane (anti-GBM) glomerulonephritis (GN) in the kidney graft is a rare event, described in limited case reports and registry analysis.…
2021 American Transplant Congress
Non-Alcoholic Fatty Liver Disease in Non-Liver Transplant Patients
R. Claudio¹, C. Conceicao², K. Robichaux², A. Kumar¹, J. Buggs³, N. Kemmer⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising at an alarming rate, driven in large part by an increased incidence of…
2021 American Transplant Congress
An Early Look at the OPTN Kidney Paired Donation Pilot Program’s New Priority Points Policy
S. E. Booker¹, R. Leishman¹, D. E. Stewart¹, T. Sandholm², J. Dickerson³, M. Pavlakis⁴, V. Casingal⁵
¹United Network for Organ Sharing, Richmond, VA, ²Carnegie Mellon University, Pittsburgh, PA, ³University of Maryland, College Park, MD, ⁴Beth Israel Deaconess Medical Center, Boston, MA, ⁵Carolinas Medical Center, Charlotte, NC
*Purpose: The OPTN implemented new policy on 10/24/19 changing how Kidney Paired Donation Pilot Program (KPDPP) priority points are awarded. The policy is intended to…
2021 American Transplant Congress
The Combined Effects of Simultaneous Portal Vein Thrombosis and Renal Dysfunction in Liver Transplant Recipients
M. Molinari¹, C. F. Carillo², D. Dongling¹, D. Jorgensen¹, S. Dharmayan¹, C. Kaltenmeier¹, H. Liu¹, J. Behari¹, V. Rachakonda¹, S. Ganesh¹, C. Hughes¹, A. Tevar¹, H. Al Harakeh¹, B. Emmanuel¹, A. Humar¹, R. Bataller¹
¹University of Pittsburgh Medical Centre, Pittsburgh, PA, ²Medicine, University of Pittsburgh Medical Centre, Pittsburgh, PA
*Purpose: Simultaneous portal vein thrombosis (PVT) and renal dysfunction (RD) have unknown effects after liver transplant (LT). We analyzed the outcomes of patients with simultaneous…
2021 American Transplant Congress
Perioperative Terlipressin Therapy Reduces the Risk of Acute Kidney Injury Post-Living Donor Liver Transplantation – A Systematic Review and Meta-analysis
A. V. Kulkarni, H. V. Tevethia, M. Sharma, P. Kumar, N. P. Rao, N. D. Reddy
Hepatology and Liver Transplantation, Asian Institute of Gastroenterology, Hyderabad, India
*Purpose: Acute kidney injury (AKI) after liver transplantation precludes calcineurin inhibitors' therapy and is associated with poor outcomes. Terlipressin (Tp) has mortality benefit in pre-transplant…
2021 American Transplant Congress
Characterization of Chronic Renal Allograft Dysfunction at Single Cell Resolution
C. Kuscu¹, C. Kuscu², A. Shetty³, M. Talwar⁴, J. Eason², D. G. Maluf⁵, V. Mas⁶
¹Surgery, James D Eason Transplant Institute, UTHSC, Memphis, TN, ²Surgery, James D Eason Transplant Institute, Memphis, TN, ³Institute for Genome Sciences, School of Medicine, University of Maryland, Baltimore, MD, ⁴Nephrology, James D Eason Transplant Institute, Memphis, TN, ⁵Surgery, Program in Transplantation - University of Maryland, Baltimore, MD, ⁶Surgery, Division of Surgical Science - University of Maryland, Baltimore, MD
*Purpose: Chronic allograft dysfunction (CAD) is one of the major complications after kidney transplantation. Hereby, we aim to assess the molecular and cellular mechanism of…
2021 American Transplant Congress
Subjective Cognition Among Liver Transplant Recipients
D. Ko¹, M. S. Dietrich², K. A. Gifford³, S. H. Ridner²
¹School of Nursing, Northeastern University, Boston, MA, ²School of Nursing, Vanderbilt University, Nashville, TN, ³Department of Neurology, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Regular assessment of cognition is highly suggested to facilitate the early detection and treatment of cognitive impairment in the liver transplant (LT) population. While…
2021 American Transplant Congress
Risk Factors for Mortality in Kidney Transplant Patients Infected by Sars-cov-2 in South of Spain
V. Lopez¹, T. Vazquez¹, C. Casas¹, I. Poveda², J. Alonso¹, D. Hernandez¹
¹Nephrology, Nephrology Department, Hospital Regional Universitario de Málaga and University of Málaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, Málaga, Spain, ²Nephrology, Nephrology Department, Hospital Torrecárdenas, Almería., Málaga, Spain
*Purpose: Covid-19 pandemic has especially affected kidney transplant (KT) recipients, who are more vulnerable than the general population due to their immunosuppressive status and added…